menu
    • menu
    [{"orgOrder":0,"company":"Kamari Pharma","sponsor":"BRM Group","pharmaFlowCategory":"D","therapeuticArea":"Rare Diseases and Disorders","country":"ISRAEL","productType":"Other Small Molecule","year":"2025","type":"Series A Financing","leadProduct":"KM023","moa":"TRPV3","graph1":"Rare Diseases and Disorders","graph2":"Preclinical","graph3":"Kamari Pharma","amount2":0.02,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Rare Diseases","amount2New":0.02,"dosageForm":"Oral","sponsorNew":"Kamari Pharma \/ BRM Group","highestDevelopmentStatusID":"4","companyTruncated":"Kamari Pharma \/ BRM Group"}]

    Find Rare Diseases and Disorders Clinical Drug Pipeline Developments & Deals by Kamari Pharma

    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Kamari Pharma

                            Israel arrow
                            DIA 2025
                            Not Confirmed

                            Kamari Pharma

                            Israel arrow
                            DIA 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : KM023

                            Therapeutic Area : Rare Diseases and Disorders

                            Study Phase : Preclinical

                            Sponsor : BRM Group

                            Deal Size : $23.0 million

                            Deal Type : Series A Financing

                            DEALS_DEV arrow-down

                            Kamari Pharma Announces Closing of $23 Million Financing

                            Details : Proceeds will be used to advance Kamari's lead program KM023, a first-in-class oral TRPV3 inhibitor, for three rare genetic skin diseases, Olmsted syndrome, severe keratoderma and ichthyosis.

                            Product Name : KM023

                            Product Type : Other Small Molecule

                            Upfront Cash : Undisclosed

                            June 03, 2025

                            Lead Product(s) : KM023

                            Therapeutic Area : Rare Diseases and Disorders

                            Highest Development Status : Preclinical

                            Sponsor : BRM Group

                            Deal Size : $23.0 million

                            Deal Type : Series A Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth